MINI FUTURE LONG - VIATRIS Share Price

Certificat

DE000PG1H4E5

Market Closed - Boerse Frankfurt Warrants 20:50:31 05/07/2024 BST
3.94 EUR -5.29% Intraday chart for MINI FUTURE LONG - VIATRIS
Current month-8.18%
1 month-4.38%
Date Price Change
05/07/24 3.93 -5.53%
04/07/24 4.16 +3.74%
03/07/24 4.01 -3.14%
02/07/24 4.14 -2.13%
01/07/24 4.23 -1.17%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 08:50 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying VIATRIS INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PG1H4E
ISINDE000PG1H4E5
Date issued 24/05/2024
Strike 6.066 $
Maturity Unlimited
Parity 1 : 1
Emission price 4.41
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.52
Lowest since issue 3.7

Company Profile

Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The Company operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.
Sector
-
More about the company

Ratings for Viatris Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Viatris Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
10.32 USD
Average target price
12.4 USD
Spread / Average Target
+20.12%
Consensus